Table.
Site of Action | Inhibitor | References |
---|---|---|
Complex I | Rotenone | Lesnefsky et al31 |
Amobarbital | Stewart et al53 | |
S-nitrosothiols | Nadtochiy et al,54 Prime et al,55 Burwell et al,56 and Nadtochiy et al57 | |
Nitrite | Shiva et al58 and Dezfulian et al59 | |
Metformin | Owen et al,60 Legtenberg et al,61 Bhamra et al,62 and Matsuzaki et al63 | |
Capsaicin | D’Alonzo et al64 and Satoh et al65 | |
Isoflurane | Hanley et al66 and Cope et al67 | |
Ranolazine | Wyatt et al68 | |
Complex II | Atpenin A5 | Wojtovich et al69 |
Diazoxide | Anastacio et al70 and Wang et al71 | |
Malonate | Chouchani et al,14 Boylston et al,72 and Wojtovich et al73 | |
Nitroxyl | Pagliaro et al74 and Shiva et al75 | |
3-Nitropropionate | Riepe et al76 | |
Nitro-alkenes | Nadtochiy et al77 | |
Complex III | Antimycin A | Kabir et al78 |
Complex IV | Nitric oxide | Zhao et al79 |
Carbon monoxide | Clark et al80 | |
Hydrogen sulfide | Khan et al,81 Pan et al,82 and Elrod et al83 |
Note: Some references are paired such that the phenomenon of a molecule inhibiting a respiratory complex and the phenomenon of it being protective in ischemia/reperfusion injury are not necessarily co-observed in the same experimental system. Inclusion of a molecule in this table should not be misconstrued as claiming that the mechanism of its protection is dependent on its effects on a given respiratory complex.